PODCAST · health
Empowered Patient Podcast
by Karen Jagoda
Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.
Episodes
-
Virtual Transitionist Model Reduces Complications after Acute Care Events with Dr. David Feldman Dimer Health
Dr. David Feldman is the Chief Medical Officer at Dimer Health, a virtual care medical practice designed to improve patient outcomes during the critical 1-3 days following hospital discharge, outpatient surgery, or emergency room visits. The company addresses the gap in post-acute care between...
-
Certified Drug Label Translations in 26 Languages for Limited English Proficient Patients with Sharon Blank RxTran
Sharon Blank, CEO of RxTran, highlights the value of certified translations of prescription dosing instructions in 26 languages to ensure that limited-English-proficient patients can understand dosing and medication risks. The organization works with pharmacies to deliver translations created by...
-
Using AI to Unify Healthcare HR Systems to Reduce Administrative Burden with Craig Ahrens Worki
Craig Ahrens is the CEO of Worki, a healthcare workforce management platform that aggregates fragmented HR records by unifying disparate data sources and deploying AI agents to streamline workflows. To address anxieties, the focus needs to be on reducing administrative burdens through intelligent...
-
Integrated Continuous Data-Driven Care for Severe Mental Illness with Sonia Garcia Amae Health
Sonia Garcia, Co-Founder and Chief Growth Officer at Amae Health, an integrated care company specializing in the treatment of severe mental illness that operates community-oriented clinics to deliver comprehensive psychiatry-led care. They provide continuity of care across multiple acuity levels,...
-
Expanding Advanced Lung Transplant Assessment and Utilization with Sarah Lowe XVIVO
Sarah Lowe, Global Clinical Operations Director at XVIVO, develops technologies to preserve, assess, and transport organs for transplantation. With advanced assessment of donor lungs, the mission is to evaluate marginal organs better to address the critical challenge that only 2 out of 10…
more -
Platform Targets Root Causes of Disease to Drive Drug Discovery with Vin Singh Bullfrog AI
Vin Singh, Founder, Chairman, and CEO of Bullfrog AI, is applying proprietary AI technology to drug development, with a focus on drug target discovery and phase three clinical trials. The company's platform is derived from the Johns Hopkins University Applied Physics Lab and is designed to…
more -
Addressing Social Drivers of Health to Improve Patient Outcomes with Dr. Greg Carroll ClinNEXUS
Dr. Greg Carroll, emergency physician and Co-Founder and CEO of ClinNEXUS, a data-first healthcare company addressing social drivers of health in underserved communities by breaking down data silos. Integrating clinical information with social, behavioral, and environmental factors and using AI…
more -
Image-Based Digital Biomarkers Detected by AI Platform to Transform Drug Development and Clinical Care with Susan Wood VIDA
Susan Wood, CEO of VIDA, develops AI-driven imaging-based biomarkers that quantitatively measure biological processes and disease states using imaging modalities such as CT, MRI, PET, and ultrasound. Unlike traditional visual image analysis, VIDA's technology extracts approximately 25,000...
-
Clinician-Supervised Purpose-Built AI Bridges Behavioral Health Therapy Gaps with Luis Voloch Jimini Health
Luis Voloch, Co-Founder and CEO of Jimini Health, focuses on mental health through the Sage platform, which provides continuous AI support for patients while keeping clinicians informed and in control. The approach addresses the problem of patients turning to general-purpose AI for behavioral...
-
Localized Immunotherapy by Direct Injection Treats Solid Tumors and Activates the Immune System with Lew Bender Intensity Therapeutics
Lew Bender, Founder and CEO of Intensity Therapeutics, has developed a novel approach to treating solid tumors through direct intratumoral injection of existing chemotherapy drugs. The company uses a proprietary formulation containing a special molecule that makes water-based drugs soluble in…
more -
How Voice AI Agents Coordinate Healthcare and Improve Patient Access with Dr. Erin Palm Infinitus
Dr. Erin Palm, medical lead at Infinitus, specializes in agentic AI for healthcare, leveraging voice technology to facilitate actions and execute tasks on behalf of providers, payers, and patients to coordinate administrative functions and patient-facing applications. These agents can handle...
-
Long-Acting Antibody Treatment for HIV/AIDS Patients with Jimmy Chang TaiMed Biologics
Jimmy Chang, Chairman and CEO of TaiMed Biologics, is approaching critical unmet needs in HIV care, particularly for aging patients with comorbidities who face risks from drug-drug interactions with multiple medications. The company is advancing the next-generation antibodies designed for…
more -
Popular Hospital Patient Experience Book Club Builds Empathy and Staff Connections with Dr. Katherine Hockman and Dilshad Marolia NYU Langone Health
Dr. Katherine Hockman, Director of the Division of Hospital Medicine at NYU Langone Health, and Dilshad Marolia, System Director of Hospitals and Regulatory and Policy Management at NYU Langone Health, are co-leaders of the Patient Experience Book Club for the hospital employees. Operating since...
-
New Dual-Action Nitric Oxide Targets Infection and Inflammation in Chronic Respiratory Disease with Nate Stasko Vast Therapeutics
Nate Stasko, CEO of Vast Therapeutics, is developing a novel nitric oxide-releasing therapy to treat chronic respiratory diseases, particularly fibrosis bronchiectasis, which is frequently misdiagnosed as asthma or COPD. Their lead drug candidate is a dual-mechanism therapy that is delivered to…
more -
Developing Freeze-Dried Blood to Transform Trauma Care with Dr. Scott Walter Defense Health Agency
Dr. Scott Walter is Director of Technology Transfer and Transition for the 59th Medical Wing of the Defense Health Agency located in San Antonio, Texas. The development of freeze-dried blood is a ground-breaking technology aimed at enabling medics to administer lifesaving blood transfusions at…
more -
Prenatal Gene Therapy for Sickle Cell Disease with Dr. Panicos Shangaris King's College London
Dr. Panicos Shangaris is from King's College London, where he is a senior clinical lecturer and consultant in maternal and fetal medicine. He discusses the treatment options for sickle cell disease, an inherited blood condition, and his work on the Pericles project, which aims to treat it before...
-
Significance of Real-World Data in the Development of Reliable Disease Registries and Smarter Clinical Trials with Mark Larkin Vitaccess
Mark Larkin, Founder and CEO of Vitaccess, leverages real-world patient data captured through mobile devices and wearables, combined with EMRs, claims data, and registries, to generate insights beyond the scope of traditional clinical trials. The company maintains proprietary disease registries,...
-
Managing Real-Time Agentic AI Security Across the Entire Enterprise with Nadav Cornberg Eve Security
Nadav Cornberg, CEO of Eve Security, highlights the need for real-time security for agentic AI in healthcare environments to enforce policies and map agentic activities within an organization. There are unique risks posed by AI, such as ambiguity from natural language commands, the potential for...
-
AI Stroke Imaging Platform Significantly Reduces Initial Decision Time for Proper Treatment with Michalis Papadakis Brainomix
Michalis Papadakis, CEO and Co-Founder of Brainomix, is developing AI technology to automate the analysis of brain scans of stroke patients, addressing the critical clinical gap where a majority of patients who should receive treatment are not being identified. The platform identifies stroke...
-
Transdermal Therapy Targets Acidity of Tumor Microenvironment to Enhance Immunotherapy Outcomes with Dr. Ryan Beal Dyve Biosciences
Dr. Ryan Beal, Founder and CEO of Dyve Biosciences, has developed a transdermal delivery approach that uses the skin to deliver agents into circulation, where they selectively neutralize the acidic tumor microenvironment. By correcting acidity, the immune system is reactivated to better recognize...
-
Trusted Identity Data Foundation of Seamless Clinical Care and Digital Engagement with Joe Hickey Verato
Joe Hickey is the Vice President of Provider Markets at Verato, which is a healthcare-focused identity management company. Identity fragmentation has been treated as a technical afterthought rather than a strategic infrastructure priority, resulting in denied claims, poor patient experience, and...
-
Microwave Ablation Provides Minimally Invasive Treatment Option for Benign Thyroid Nodules with Mark Saxton Baird Medical
Mark Saxton, CEO of Baird Medical, highlights their microwave ablation technology, which is being used to address a significant treatment gap for benign thyroid nodules. This minimally invasive approach is an alternative to radiofrequency ablation, accommodates patients with pacemakers or other...
-
Open-Source Focused Ultrasound and Infrared MedTech to Advance Stroke Diagnosis and Neurological Therapies Aaron Timm Openwater
Aaron Timm, CEO of Openwater, is driving the shift from single-purpose, room-sized equipment to multi-purpose, portable, light-weight medical devices designed on an open-source platform. Some tools use infrared light to measure blood flow in real time for applications such as stroke detection....
-
Multi-Target T Cell Engagers Transforming Treatment for Solid Tumors with Jack Silberstein Deck Bio
Jack Silberstein, CEO of Deck Bio, is developing next-generation T cell engagers designed to activate the patient's immune system to shrink tumors. These T cell engagers are bispecific molecules that alert immune cells to recognize targets on cancer cells and kill them by binding to both the…
more -
Building an AI and Data-Driven Holistic View of Patient Health with Professor Linda Macomber Renaissance Health
Professor Linda Macomber, a healthcare tech consultant at Renaissance Health, highlights the transformative potential of AI and digital health solutions, as well as the shift from siloed, symptom-focused care to holistic, personalized medicine. AI applications in healthcare have moved from...
-
DNA Sequencing Tests Identify Causes of Infections in Immunocompromised Patients with Alec Ford Karius
Alec Ford, CEO of Karius, has developed an innovative approach to diagnosing infections in immunocompromised patients, using DNA sequencing of blood samples to identify over 1,300 causes of infection within 24 hours. Traditional diagnostic methods rely on hypothesis-driven testing and the...
-
Rapid Exome and Genome Testing for the Diagnosis of Rare Diseases with Lisa Gurry GeneDx
Lisa Gurry, Chief Business Officer at GeneDx, is transforming the diagnosis of rare diseases in children by providing comprehensive genetic testing. Using exome and genome sequencing, they deliver rapid, accurate results that enable early intervention and access to therapies. Through partnerships...
-
Combating AMR with Cutting-Edge Antimicrobials That Outsmart Multidrug-Resistant Bacteria with Kelvin Cooper Lakewood-Amedex
Kelvin Cooper, CEO of Lakewood-Amedex Biotherapeutics, has developed a novel class of antimicrobials that operate by disrupting bacterial and fungal cell membranes, rapidly killing the microorganisms. Traditional antimicrobials work by inhibiting bacterial growth, but bacteria have evolved...
-
Targeting Root Causes of Obesity and Metabolic Disease with Harith Rajagopalan Fractyl Health
Harith Rajagopalan, Co-Founder and CEO of Fractyl Health, is developing innovative therapies that target the root causes of obesity and metabolic diseases to achieve durable, long-lasting patient outcomes. Their drug is designed to address post-GLP-1 rebound weight gain by treating the underlying...
-
Using Exosomes-Based Therapy to Restore Function After Traumatic Spinal Cord Injury with Lior Shaltiel NurExone
Lior Shaltiel, CEO of NurExone, is addressing the unmet needs of those with spinal cord injuries, as current therapies only treat symptoms and do not regenerate damaged nerves from accidents or disease. The NurExone technology aims to stimulate nerve growth by targeting a protein that inhibits…
more -
Harnessing Conversational AI to Reduce Healthcare Workflow Friction and Clinician Burnout with Peter Swimm Toilville
Peter Swimm, Founder of Toilville, is a conversational AI pioneer, and he describes the transformation in healthcare resulting from the use of AI and large language models to address clinician burnout and improve patient outcomes. He emphasizes that technology should adapt to practitioners'...
-
Reformulating Diabetes Drug to Treat Degenerative Eye Diseases with Richard Garr Curative Biotechnology
Richard Garr, CEO and General Counsel of Curative Biotechnology, discusses the company's work in repurposing the diabetes drug metformin into an eye drop for degenerative eye diseases. The goal of the therapy is retinal preservation, aiming to slow or stop disease progression by acting at the...
-
Immersive Precision Neurotherapy for Stroke and Parkinson's Rehabilitation with Zach Henderson MindMaze Therapeutics
Zach Henderson, CEO at MindMaze Therapeutics, has designed a precision neurotherapeutic solution designed to offer a scalable, engaging and immersive platform for patients recovering from strokes or managing Parkinson's disease. The solution is deployed across the entire care continuum from...
-
Cloud-Based Vendor-Agnostic EEG Platform Unifies and Standardizes Data with Daniele De Mari Neurogram
Daniele De Mari, Founder and CEO of Neurogram, points out the significant problem of non-standardized data formats in EEG (electroencephalography), compared to the universal standard used in radiology. Neurogram has developed a hardware-agnostic, cloud-based solution that standardizes EEG data…
more -
Autonomous Asynchronous Robots for Secure Medical Sample Transport with Dan O'Toole Arrive AI
Dan O'Toole, Founder and CEO of Arrive AI, is bringing asynchronous autonomous delivery systems to healthcare environments, enabling robots and drones to make deliveries without the recipient needing to be present. The goal is to automate logistical tasks to solve major inefficiencies in…
more -
Advanced Molecular Diagnostics Transform Skin Cancer Risk Stratification with Dr. Matthew Goldberg Castle Biosciences
Dr. Matthew Goldberg, Senior Vice President for Medical at Castle Biosciences, discusses the uncertainty clinicians face when determining treatments for skin cancer due to the limitations of traditional pathology reports. Castle's gene expression profile tests were developed to improve the…
more -
Novel Oral Therapy Targets Inflammation and Fibrosis in Pulmonary Arterial Hypertension with Sten Sörensen Cereno Scientific
Sten Sörensen, CEO of Cereno Scientific, discusses work on epigenetic modulation to treat the rare disease Pulmonary Arterial Hypertension, a progressive and fatal condition for which current treatments primarily manage symptoms. Core pathological processes of PAH include inflammation, fibrosis,...
-
Low-Nicotine Hemp Blend Cigarettes Aim to Reduce Smoking Harm with Joseph Pandolfino Cabbacis
Joseph Pandolfino, Founder and CEO of Cabbacis, is focused on reducing harm caused by smoking cigarettes by developing cigarettes made from a blend of low-nicotine tobacco and hemp. This approach is intended to help smokers reduce their nicotine dependence and increase the success rate of those…
more -
Using Unified Data and AI to Reduce Denied Claims and Improve Hospital Revenue Cycle Management with Brian Robertson VisiQuate
Brian Robertson, Founder and CEO of VisiQuate, describes the relationship between payers and providers, noting that payers have the advantage due to unified data and lower complexity than providers face. He emphasizes that providers could level the playing field by unifying their data and...
-
Guidance for Myeloma Patients and Caregivers with Debra Berenson Institute for Myeloma & Bone Cancer Research
Debra Berenson is Chair of the Fundraising Committee at the Institute for Myeloma & Bone Cancer Research and author of two books- I Have WHAT and You Have WHAT, based on her personal experience and the expertise of her husband, Dr. Jim Berenson, a myeloma expert. Multiple myeloma and related bone...
-
Quantitative Ultrasound Non-Invasive Portable AI-Powered Solution for Disease Detection and Monitoring with Anthony Tardi Samsung HME America
Anthony Tardi, head of ultrasound and radiology CT at Samsung HME America, is developing non-invasive, portable tools such as quantitative ultrasound to enable earlier detection of diseases that can be reversed if caught early. AI is being used to automate tedious, clerical tasks in imaging,...
-
Speeding Payments and Reducing Denials for Hospitals with AI-Powered Utilization Management with Dr. Heather Bassett Xsolis
Dr. Heather Bassett, Chief Medical Officer at Xsolis, is using AI to reduce friction between healthcare providers and payers in the utilization management and mid-revenue cycle space. Their Care Level Score is a data-driven metric derived from patient data to reduce manual processes, denials, and...
-
How Pharmacogenomics Testing Reduces Polypharmacy Risks with Dr. Houda Hachad Aranscia
Dr. Houda Hachad, Vice President of Clinical Operations at Aranscia, highlights the importance of regular medication reviews in an age of growing polypharmacy and advancements in the use of pharmacogenomics to identify potential risks. The key goal is to use the minimal effective dose of a...
-
Digital Stroke Rehabilitation App Broadens Accessibility to Neurological Care with Selena Freisens Merz Therapeutics
Selena Freisens, Head of Global Medical Affairs at Merz Therapeutics, is focused on increasing access to tools to support neurological health. They have developed a digital app iFlexo, which is designed to provide at-home physiotherapy for stroke survivors. The app has been tested in Nigeria and...
-
Accelerating Bipolar Disorder Research to Transform Diagnosis and Treatments with Cara Altimus and Emily Baxi BD2
Cara Altimus, the CEO of BD², and Emily Baxi, the Program Director of BD²'s Integrated Network, are focused on integrating research and clinical care to improve outcomes for people with bipolar disorder. They emphasize the gaps in diagnostics and effective treatments and the need to collect...
-
Vertical AI Integration Addresses Healthcare Workflow Coordination with Sundar Subramanian Zyter
Sundar Subramanian, CEO of Zyter, points out that the primary issue in healthcare is not a lack of AI intelligence but a failure in AI execution. He advocates for a vertical AI integration approach that solves entire domain-specific workflows rather than horizontal or point solutions that…
more -
Biofield Therapy Shown to Reduce Pancreatic Cancer Cell Growth and Metastasis with Dr. Lorenzo Cohen UT MD Anderson Cancer Center
Dr. Lorenzo Cohen, Director of the Integrative Medicine Program at The University of Texas MD Anderson Cancer Center. He's also co-lead author of a study on whether biofield therapy can impact pancreatic cancer. The study demonstrated that biofield therapy could decrease cancer cell…
more -
Accelerating Drug Development for Rare Kleefstra Syndrome with Geoff Rhyne IDefine
Geoff Rhyne, Co-Founder and CEO of IDefine, discusses the mission to advance research into Kleefstra syndrome, a rare genetic disorder, and to find a treatment where there is currently none. This organization of parents of children with KS is advocating for broader genetic sequencing to identify…
more -
Smart Mini Robots and Biomimetic Mitral Valves Set to Transform Advanced Cardiac Care with Dr. Philippe Pouletty Carvolix
Philippe Pouletty, M.D., CEO of Truffle Capital and Founder of Carvolix, describes the evolution of heart valve replacement and the significance of AI-guided robotics in expanding access to transcatheter procedures. The company's biomimetic mitral valve and AI software that guides valve placement...
-
Using Longitudinal Sleep Data as a Vital Sign to Predict Disease Risk with Colin Lawlor Sleep ai
Colin Lawlor, CEO of Sleep ai, is focused on exploring sleep intelligence and sleep as a vital sign of health. The Sleep ai platform measures sleep longitudinally using data from consumer wearables and smartphones, with an emphasis on night-to-night variability, which is not captured in a...
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.
HOSTED BY
Karen Jagoda
Loading similar podcasts...